Overview

Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)

Status:
Not yet recruiting
Trial end date:
2026-03-31
Target enrollment:
Participant gender:
Summary
This study is a multicentre, randomized controlled trial of ivabradine versus placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Jagiellonian University
Collaborators:
Population Health Research Institute
Vanderbilt University Medical Center